Structure of the human transcription factor TFIIF revealed by limited proteolysis with trypsin  by Yong, Cai et al.
Structure of the human transcription factor TFIIF revealed by limited
proteolysis with trypsin
Cai Yonga, Hiromichi Mitsuyasub, Zhang Chuna, Satoru Oshiroa, Naotaka Hamasakib,
Shigetaka Kitajimaa;*
aDepartment of Biochemical Genetics, Medical Research Institute, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku,
Tokyo 113-0034, Japan
bDepartment of Clinical Chemistry and Laboratory Medicine, Faculty of Medicine, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812, Japan
Received 18 June 1998; revised version received 14 August 1998
Abstract In this study, the human general transcription factor
IIF (TFIIF), a heteromeric complex of RAP74 and RAP30
subunits, was subjected to limited proteolysis with trypsin. The
central region of RAP74 was demonstrated to be highly sensitive
to trypsin while both the N- and C-terminal regions contained
trypsin-resistant structures. In contrast, RAP30 digestion
occurred after proteolysis of RAP74. The digestion pattern of
RAP74 recruited into the preinitiation complex showed no
marked difference from that of IIF, while RAP30 in the complex
was protected from trypsin. These results indicate that RAP74
apparently contains three structural domains, the central one of
which is externally surfaced and unstructured, but RAP30 is
internally wrapped by RAP74. Furthermore, the accessibility of
the central region of RAP74 is unaltered in the minimal
preinitiation complex, while RAP30 is involved in promoter
recognition through its DNA binding activity.
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1. Introduction
The mRNA synthesis of class II genes in vitro is carried out
by the transcription machinery, a multiprotein complex com-
posed of general or basal transcription factors including RNA
polymerase II. These factors (TFIIB, -D, -E, -F, and -H) that
assemble on the minimal promoter sequence of the gene have
speci¢c functions and interact with each other to produce a
competent initiation complex [1^3]. Among these factors,
TFIIF is unique in that it functions in both initiation and
elongation [4^7]. In the initiation step, IIF recruits RNA pol-
ymerase II into the preformed complex of TBP (TATA-bind-
ing protein), IIB, and promoter DNA [8,9]. RAP30 interacts
with RAP74 and RNA polymerase II through its N-terminal
and central sequences, respectively [10^12]. Its C-terminus ex-
hibits cryptic DNA binding activity [13,14]. RAP74 is also
required for reconstitution of both the initiation and elonga-
tion activities of IIF [4,5,7,15^17]. Functional analyses of
RAP74 have revealed that its N-terminal sequence interacts
with RAP30, and is essential and su⁄cient for supporting the
in vitro transcription [11,18,19]. The RAP74 structure de-
duced from the cDNA sequences of human [15,16], Xenopus
[20], and Drosophila [21,22] contained two highly conserved
N- and C-terminal sequences with a long central region rich in
acidic and basic charged amino acids. The central region also
contains many possible phosphorylation sites [11,23] whose
state upregulates transcriptional activity [24]. For Drosophila,
two more subregions were reported [22]. However, the signi¢-
cance of these regions, especially that of the central charged
and C-terminal regions, remains unknown. In this study,
TFIIF was expressed as a native hetero-complex of RAP30
and RAP74 in insect cells, and subjected to trypsin digestion
in order to determine its native structure in the free form and
preinitiation complex. The results showed that the trypsin-
sensitive region of RAP74 is clustered in the central domain
while both the N- and C-terminal portions contain trypsin-
resistant structures. The digestion pattern of RAP74 in the
minimal preinitiation complex remained unchanged but
RAP30 became more resistant.
2. Materials and methods
2.1. Recombinant human transcription initiation factors
TFIIF was expressed in an insect cell line, SF21 cells, by co-trans-
fection of baculoviruses harboring cDNA encoding each subunit of
IIF as described [17]. Approximately 2U107 cells in a 175-cm2 £ask
were infected with a mixture of 3U108 pfu each of BAKPAK6/
RAP74 and BAKPAK6/RAP30 baculoviruses [17] in 10 ml of Grace’s
medium containing 10% fetal bovine serum at room temperature for
1 h. After further incubation at 27‡C for 60 h, the cells were harvested
and resuspended in 4 ml of ice-cold bu¡er (20 mM Tris-HCl, pH 7.9,
and 5 mM 2-mercaptoethanol) containing 5 Wg/ml each of antipain,
leupeptin, pepstatin, chymostatin, elastatinal, and phosphoramidon.
After the cells had been lysed with a Dounce homogenizer, cell ex-
tracts containing expressed IIF were obtained by centrifugation of the
homogenates at 35 000 rpm for 60 min. The extracts were then applied
to a phosphocellulose (P11) column equilibrated with bu¡er B (20 mM
Tris-HCl, pH 7.9, 0.1 mM EDTA, 10% glycerol, and 5 mM
2-mercaptoethanol) containing 0.3 M NaCl. After washing with the
same bu¡er, IIF was eluted with bu¡er B/0.6 M NaCl. The fraction
containing IIF was diluted to bu¡er B/0.1 M NaCl by the addition of
bu¡er B, applied to a Q-Sepharose column equilibrated with bu¡er B/
0.1 M NaCl, and then eluted with a linear gradient of NaCl from 0.1
to 0.6 M. IIF was eluted at 0.25 M NaCl and was approximately 95%
pure. Human TBP (TATA box-binding protein) and both subunits of
IIE that contained a (histidine)6 tag at their N-termini were expressed
in E. coli strain BL21(DE3) cells, using the pET15b expression vector,
and puri¢ed by nickel chromatography on a Pro-Bond resin according
to the recommended protocol. Recombinant human IIB was obtained
as described [25]. Rat liver IIH was kindly provided by Dr. Aso at
Tsukuba University, Japan, and human RNA polymerase II was pu-
ri¢ed from HeLa cells as described [24]. The purities of the factors
estimated on SDS-PAGE analysis were approximately 95, 95, 90, 60,
and 70% for TBP, IIB, IIE, IIH, and RNA polymerase II, respec-
tively.
2.2. DBPolF or DBPolFEH complex formation
Approximately 10 pmol of each basal transcription factor was used.
The amount of TFIIF was substoichiometric as to other basal factors
in order to assure complete recruitment of IIF into the complex.
Brie£y, 0.38 Wg TBP and 0.32 Wg IIB were ¢rst incubated with
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0.53 Wg DNA fragment of the adenovirus major late promoter se-
quence from 355 to +33 in 60 Wl of bu¡er A (20 mM HEPES-
KOH, pH 7.5/0.1 mM EDTA/50 mM KCl/10% glycerol) containing
5 mM MgCl2 and 6 Wg poly(dG-dC) at 30‡C for 30 min. Then, 1 Wg
polymerase II (PolII) and 0.34 Wg IIF were added in a total volume of
100 Wl for the DBPolF complex. A mixture of 0.42 Wg IIE and 0.80 Wg
IIH was further included for DBPolFEH complex formation. The
mixture was further incubated for another 30 min for the complex
to assemble. Under these conditions, the preinitiation complex forma-
tion was detected by gel shift assay as described in [24].
2.3. Trypsin digestion
IIF alone, bound to RNA polymerase II, or recruited into the
DBPolF or DBPolFEH complex in bu¡er A was digested with the
indicated amounts of trypsin at 30‡C. At each time interval, the re-
action was stopped by adding a 15-Wl aliquot to SDS-PAGE sample
bu¡er, followed by heating at 95‡C. After separation by 12% SDS-
PAGE, the RAP74 digestion products were visualized by silver-stain-
ing or Western blotting.
2.4. In vitro transcription assay
The in vitro transcription activity was assayed as described [24].
Brie£y, the preinitiation complex was assembled by preincubation of
pAdML(C2AT) containing the promoter sequence of the adenovirus
major late gene and a G-less cassette [24] with TBP, IIB, IIE, IIF, rat
IIH, and human RNA polymerase II. Transcription was initiated by
adding a mixture of nucleoside triphosphates to a ¢nal concentration
of 600 WM ATP and UTP, and 25 WM K-32P-CTP (3000 Ci/mmol),
followed by further incubation for 60 min. RNA transcripts were
analyzed on a 6% polyacrylamide/7 M urea gel, and visualized by
autoradiography.
2.5. Other procedures
One mg/ml trypsin (Boehringer Mannheim) was prepared in 1 mM
HCl and used after appropriate dilution. The conditions of Western
blotting, including electro-transfer to a nitrocellulose membrane,
blocking, and detection with chemiluminescent reagent CSPD, were
as described [26]. Antibodies against full length RAP74 or RAP30
were prepared as described previously [11], anti-RAP74 (N-16) or
anti-RAP74 (C-18) antibodies against the N-terminal 43^58 or C-ter-
minal 498^515 amino acids of RAP74, respectively, were obtained
from Santa-Cruze. Anti-TBP and anti-IIB antibodies were also pur-
chased from Santa-Cruze.
3. Results
3.1. Susceptibility of the RAP74 subunit to trypsin digestion
Recombinant IIF was treated with trypsin for various peri-
ods and then analyzed by SDS-PAGE. As shown in Fig. 1A,
RAP74 was easily digested after short exposure to trypsin and
several small digestion fragments were produced (Fig. 1A,
lanes 1^7). These fragments were relatively resistant to trypsin
since their densities showed no remarkable decrease on further
digestion. Among the bands, three major ones of 27, 24, and
22 kDa reacted with both anti-full and anti-N-terminal (43^
58) RAP74 antibodies (Fig. 1B, lanes 1^4), demonstrating that
these bands represent N-terminal fragments. Two bands of 15
and 13 kDa were detected with both anti-full and anti-C-ter-
minal 498^515 antibodies (Fig. 1B, lanes 1, 2, 5, and 6). When
the bands detected on Western blotting were compared with
silver-stained proteolytic fragments, it became evident that
there were no bands which did not react with anti-N- or
anti-C-terminal antibodies. This indicates that the relatively
broad region between the N- and C-terminal sequences was
digested into very small fragments under these conditions. In
fact, no fragments smaller than the N- or C-terminal ones
were detected on 17% SDS-PAGE in Tris-Tricine bu¡er that
was employed for smaller peptide analysis (data not shown).
In contrast, the density of RAP30 exhibited only a small re-
duction when non-digested full-sized RAP74 remained. How-
ever, its digestion rapidly progressed after completion of
RAP74 digestion and produced a 13-kDa fragment. These
data indicate that RAP74 contains a trypsin-resistant globular
conformation at both its N- and C-termini, but a trypsin-
sensitive structure in its central region. RAP30, on the other
hand, is protected from trypsin by RAP74 since it was di-
gested after RAP74.
3.2. Limited proteolysis of the IIF-RNA polymerase II complex
TFIIF has been shown to bind to RNA polymerase II
(PolII) in solution and stimulate its elongation rate of
mRNA synthesis [3^6]. The IIF-PolII complex was formed
in the presence or absence of DNA, and treated with trypsin.
The digestion pro¢le of RAP74 detected with anti-full RAP74
antibody was essentially the same as that of IIF regardless of
the presence or absence of DNA (data not shown).
3.3. Limited proteolysis of IIF in the preinitiation complex
Basal transcription in vitro requires a set of general factors.
We assayed the in vitro transcription activity reconstituted
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Fig. 1. Eight Wg of baculovirus-expressed IIF was subjected to tryp-
sin digestion in a ratio of 1600:1 (IIF to trypsin) at 30‡C for the in-
dicated times and the aliquots were analyzed by 11% SDS-PAGE.
A: Tryptic fragments were visualized by silver staining. Lane 1:
Size marker; lanes 2^8: samples incubated for 0, 1, 3, 5, 10, 20,
and 30 min, respectively. Closed squares and open circles indicate
major N-terminal and C-terminal fragments, respectively. B: IIF
treated with trypsin for 0 (lanes 1, 3, and 5) and 20 min (lanes 2, 4,
and 6) were analyzed by Western blotting using anti-full length
RAP74 (lanes 1 and 2), anti-N-terminal 43^58 (lanes 3 and 4), or
anti-C-terminal 498^515 amino acid antibodies (lanes 5 and 6), re-
spectively. In lanes 7^12, IIF digested for 0, 3, 5, 10, 20, and 30
min was analyzed by Western blotting using anti-RAP30 antibody.
The open triangle indicates the 13-kDa major proteolytic fragment
of RAP30.
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with our preparations of general transcription factors. TBP,
IIB, IIF, IIE, IIH, and PolII were all minimal requirements
for the activity as shown in Fig. 2. Omission of any factor
from the complete reaction mixture totally abolished the tran-
scription activity. This indicated that our factors are capable
of supporting the in vitro transcription activity and are not
contaminated by each other. Using these factors, the preini-
tiation complex (PIC) was assembled and then subjected to
trypsin digestion. As shown in Fig. 3A, the digestion of
RAP74 in the DBPolFEH complex proceeded essentially
with the same time course as that for PIC without DNA.
Three major N-terminal bands and fragments in the 14-kDa
region were protected from digestion, as in the case of IIF,
and no speci¢c digestion fragments were produced. Fig. 3B,
however, shows that RAP30 digestion was evidently inhibited
in PIC with promoter DNA compared with that without
DNA. This is likely due to the interaction of RAP30 with
promoter DNA. This inhibition of RAP30 digestion was
also observed for the DBPolF complex with promoter
DNA, but not for that without DNA (data not shown).
TBP was also protected from trypsin in PIC with promoter
DNA in our assay (data not shown).
4. Discussion
Bacterially expressed RAP30 and RAP74 can associate, but
very ine⁄ciently in vitro even after denaturation of the two
proteins in urea and subsequent renaturation [4,27]. In con-
trast, co-expression of RAP30 and RAP74 in insect cells
yielded an assembled form of active IIF (Fig. 2 and [17]). In
fact, the insect-cell expressed IIF showed the same biochem-
ical properties as native IIF puri¢ed from HeLa cells ; that is,
a stoichiometric heterotetramer of RAP30 and RAP74, the
same speci¢c activity of initiation and elongation of transcrip-
tion, and similar behavior on column chromatography (data
not shown). Thus, it is necessary to use well-assembled IIF
rather than independently expressed RAP30 or RAP74 for a
structural study.
In this study, we found that the central region of RAP74 is
highly sensitive to trypsin and externally surfaced, but N- and
C-terminal regions contain trypsin-resistant structures.
Although the amino acid sequences of the tryptic fragments
were not determined, comparison of their sizes on SDS-PAGE
with those of RAP74 deletion mutants [11] allowed us to
predict that the N- and C-terminal fragments comprise of
the N-terminal 180^200 and C-terminal 130^150 amino acids,
respectively. Mutagenesis of RAP74 revealed that its N-termi-
nal sequence of 1^172 [18] or 1^205 [11,19,29] interacts with
RAP30, and is essential for the ability of in vitro transcription
initiation. Our ¢nding that the N-terminal 22^27-kDa region
is resistant to trypsin digestion supports the idea that this
region has a globular structure, or that it is protected due
to the interaction with RAP30. This provides structural evi-
dence for the function of this region of RAP74. RAP74 was
also found to interact with IIB [28], PolII and DNA [18] in
assays using bacterially-expressed mutants of RAP74 at its C-
terminal 358^517, 363^444, and 363^486 sequences, respec-
tively. The present analysis using the in vivo-assembled IIF
demonstrated that RAP74 contains another trypsin-resistant
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Fig. 3. Trypsin digestion of the in vitro-assembled DBPolFEH com-
plex. The DBPolFEH complex was assembled with (lanes 1^7) or
without (lanes 8^14) minimal promoter DNA in vitro as described
in Section 2. The complex was then digested with trypsin in a ratio
of 200:1 (DBPolFEH/trypsin) for 0 (lanes 1 and 8), 1 (lanes 2 and
9), 3 (lanes 3 and 10), 10 (lanes 4 and 11), 20 (lanes 5 and 12), 30
(lanes 6 and 13), and 50 min (lanes 7 and 14), respectively, sepa-
rated by 11% SDS-PAGE, and analyzed by Western blotting using
anti-RAP74 (A) or anti-RAP30 antibodies (B). The closed squares,
open circle in A, and the open triangle in B indicate major N-termi-
nal, C-terminal fragments of RAP74, and the 13-kDa proteolytic
fragment of RAP30, respectively.
Fig. 2. Reconstitution of the in vitro transcription activity using
general transcription factors. Recombinant TBP, IIB, IIF, IIE, and
puri¢ed IIH were employed for reconstituting the in vitro transcrip-
tion activity as described in Section 2. Lanes 1 and 9: Complete;
lanes 2^7: activity in the absence of TBP, IIB, IIF, IIE, IIH, or
RNA polymerase II, respectively; lane 8: complete in the presence
of 1 Wg/ml K-amanitin. The arrow indicates the band of the correct
transcript.
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structure of approximately 130^150 amino acids length at its
C-terminus. However, the signi¢cance of these interactions
was not evaluated in this study since the digestion pattern
of RAP74 did not change signi¢cantly in the IIF-PolII,
DBPolF, or DBPolFEH complex. It is possible that these
interactions are neither strong nor stable enough to be as-
sayed by means of trypsin digestion. Alternatively, bacteria-
expressed RAP74 might contain a structure di¡erent from
that of assembled IIF, and exposes cryptic sequences for
IIB, PolII, or DNA binding whose function is apparent
only in a more complex system than the re¢ned in vitro-as-
sembled assay. In fact, the C-terminus of RAP74 is dispensa-
ble for both in vitro initiation and elongation of transcription
[18,19,29]. The central region of RAP74, approximately 200^
360 amino acids, is considered to be exposed to the outside of
the IIF molecule and to have a random structure. This might
be due to its notably high content of charged amino acids:
several runs or clusters of positive, negative, and mixed amino
acids in the 233^252, 302^326, and 180^213 sequences, respec-
tively [23].
RAP30, which is considered to be internally protected by
RAP74, became trypsin-resistant in the preinitiation complex
containing DNA. It is apparent that this is due to a confor-
mational change of RAP30 evoked by the DNA binding ac-
tivity at its C-terminus. RAP30 is considered to be involved in
the formation of a stable PIC around promoter DNA, in
concert with TBP whose digestion by trypsin was also pre-
vented in PIC (data not shown). RAP30 strongly interacted
with the coding strand just downstream of TBP at 319 of
adenovirus major late promoter DNA [30].
Finally, this study provided some information as to the
native structure of TFIIF and might shed light on the struc-
tural basis of unique function of IIF in both the initiation and
elongation of transcription by RNA polymerase II.
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